Results 61 to 70 of about 1,781,086 (356)

Common Barriers to Reporting Medical Errors

The Scientific World Journal, 2021
Background. Medical errors are the third leading cause of death in the United States. Reporting of all medical errors is important to better understand the problem and to implement solutions based on root causes.
Salim Aljabari, Zuhal Kadhim
doaj   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Color vision deficiency

مجله دانشگاه علوم پزشکی گرگان, 2016
Color vision deficiency (CVD) is a defect of vision with disability to distinguish colors. Color vision deficiency can be divided into the two categories, congenital and acquired.
M Mahjoob M, H Ostadimoghaddam H, S Heydarian   +2 more
doaj  

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Diagnostic Medical Errors: Patient\u27s Perspectives on a Pervasive Problem [PDF]

, 2017
Introduction. The Institute of Medicine defines diagnostic error as the failure to establish an accurate or timely explanation for the patient\u27s health problem(s), or effectively communicate the explanation to the patient. To our knowledge, no studies
Couperus, Cody J, Kolli, Sree Sahithi, Munoz, Sergio Andres, Reeves, Russell R, Repp, Allen B., Self, Quinn, Worswick, Erica, York, Sterling A.   +7 more
core   +1 more source

Medical errors in primary care clinics – a cross sectional study

BMC Family Practice, 2012
Background Patient safety is vital in patient care. There is a lack of studies on medical errors in primary care settings. The aim of the study is to determine the extent of diagnostic inaccuracies and management errors in public funded primary care ...
Khoo Ee Ming, Lee Wai Khew, Sararaks Sondi, Abdul Samad Azah, Liew Su May, Cheong Ai Theng, Ibrahim Mohd Yusof, Su Sebrina HC, Mohd Hanafiah Ainul Nadziha, Maskon Kalsom, Ismail Rohana, Hamid Maimunah A   +11 more
doaj   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Orbit Error Correction on the High Energy Beam Transport Line at the KHIMA Accelerator System

, 2016
For the purpose of treatment of various cancer and medical research, the synchrotron based medical machine under the Korea Heavy Ion Medical Accelerator (KHIMA) project have been conducted and is going to treat the patient at the beginning of 2018.
An, Dong Hyun, Hahn, Garam, Park, Chawon, Yim, Heejoong   +3 more
core   +1 more source

Improving disclosure of medical error through educational program as a first step toward patient safety [PDF]

, 2017
Participant’s Response to medical errors. Description of data: Raw data of participant’s response to medical errors (3 clinical cases with different severity of error outcome), satisfaction and change after the education program.
Chan Woong Kim, Eun Kyung Eo, Sun Jung Myung, Yerim Chang   +3 more
core   +6 more sources

Medical Errors Disclosure: Is It Good or Bad? [PDF]

Hospital Practices and Research, 2018
Background: In the treatment and health process, there are a lot of dangers to patients, and the increased number of medical errors is one of the most important circumstances of this process.
Amirashkan Nasiripour, Pouran Raeissi, Mehrnoosh Jafari   +2 more
doaj   +1 more source